array:42 [
  "USER" => "www-data"
  "HOME" => "/var/www"
  "SCRIPT_NAME" => "/index.php"
  "REQUEST_URI" => "/news/fda-approves-bridgebio-pharmas-drug-for-rare-heart-disease-poised-to-challenge-pfizer-in-lucrative-yet-competitive-market"
  "QUERY_STRING" => ""
  "REQUEST_METHOD" => "GET"
  "SERVER_PROTOCOL" => "HTTP/1.1"
  "GATEWAY_INTERFACE" => "CGI/1.1"
  "REDIRECT_URL" => "/news/fda-approves-bridgebio-pharmas-drug-for-rare-heart-disease-poised-to-challenge-pfizer-in-lucrative-yet-competitive-market"
  "REMOTE_PORT" => "51224"
  "SCRIPT_FILENAME" => "/var/www/dev.stocks.news/public_html/public/index.php"
  "SERVER_ADMIN" => "[no address given]"
  "CONTEXT_DOCUMENT_ROOT" => "/var/www/dev.stocks.news/public_html/public"
  "CONTEXT_PREFIX" => ""
  "REQUEST_SCHEME" => "https"
  "DOCUMENT_ROOT" => "/var/www/dev.stocks.news/public_html/public"
  "REMOTE_ADDR" => "216.73.217.50"
  "SERVER_PORT" => "443"
  "SERVER_ADDR" => "172.31.25.252"
  "SERVER_NAME" => "dev.stocks.news"
  "SERVER_SOFTWARE" => "Apache/2.4.52 (Ubuntu)"
  "SERVER_SIGNATURE" => "<address>Apache/2.4.52 (Ubuntu) Server at dev.stocks.news Port 443</address>\n"
  "PATH" => "/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin:/sbin:/bin:/snap/bin"
  "HTTP_HOST" => "dev.stocks.news"
  "HTTP_ACCEPT_ENCODING" => "gzip, br, zstd, deflate"
  "HTTP_COOKIE" => "XSRF-TOKEN=eyJpdiI6ImZJWkoxd1ZUNUJkWG9SazhJVGRjS2c9PSIsInZhbHVlIjoiajRXYytYeTN2MUVNRHA4cnpRZ1RKSkVLVlIyQkx0SHRXaGZiTHFFMkIrY00rSHVUTWZUdnBUOHdyZTNJeGlJbVVDQzhaUG1veUpRQlpoakRXMmVRbXcyZFZlbU5rR1hOUm1Ra0plRUxDNzkyamtBVnZUSVpHY3AvZjFlYlk1NnUiLCJtYWMiOiI0MDk2YjE3ZTFhOTc0YTU4NDM0M2NmYjVhZDEwNzhlYjNmZTc0MTM4NmMxNWQ3OTkxOTc4MmUzMWU1ZTg3OTc4IiwidGFnIjoiIn0%3D; stocks_news_session=eyJpdiI6Imx6YTJmd0FTMTVmWkQ4VGdsTmRnUFE9PSIsInZhbHVlIjoicFd5c0J0U0JwWEh6OG5BQkptT01SMEdEbmpYZFVrSXBzeG5ZWHA2bjFwSmJmWkVpazZTdWFNM3Q4ZzY1SUUwdE04RXBTa2hpTGdMUDRoUHJ5SGNYdE1aRkQwOWpiMGVEdWlZVTVQMHk0ZDZ3OGg5WTA1cHlacDNHWjFCNG55dTkiLCJtYWMiOiIwMzMxZDY5ZmQ2YTBhMTA5OWJjNDVjOGJiNzFlMGMyMDBlYjc4ZDdhM2E1MDU5OGQ5ZWNjYTM2N2I2Mzc5YjU5IiwidGFnIjoiIn0%3D"
  "HTTP_USER_AGENT" => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)"
  "HTTP_ACCEPT" => "*/*"
  "proxy-nokeepalive" => "1"
  "SSL_TLS_SNI" => "dev.stocks.news"
  "HTTPS" => "on"
  "SCRIPT_URI" => "https://dev.stocks.news/news/fda-approves-bridgebio-pharmas-drug-for-rare-heart-disease-poised-to-challenge-pfizer-in-lucrative-yet-competitive-market"
  "SCRIPT_URL" => "/news/fda-approves-bridgebio-pharmas-drug-for-rare-heart-disease-poised-to-challenge-pfizer-in-lucrative-yet-competitive-market"
  "REDIRECT_STATUS" => "200"
  "REDIRECT_SSL_TLS_SNI" => "dev.stocks.news"
  "REDIRECT_HTTPS" => "on"
  "REDIRECT_SCRIPT_URI" => "https://dev.stocks.news/news/fda-approves-bridgebio-pharmas-drug-for-rare-heart-disease-poised-to-challenge-pfizer-in-lucrative-yet-competitive-market"
  "REDIRECT_SCRIPT_URL" => "/news/fda-approves-bridgebio-pharmas-drug-for-rare-heart-disease-poised-to-challenge-pfizer-in-lucrative-yet-competitive-market"
  "FCGI_ROLE" => "RESPONDER"
  "PHP_SELF" => "/index.php"
  "REQUEST_TIME_FLOAT" => 1788113189.7118
  "REQUEST_TIME" => 1788113189
]
Stocks News

FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market

Select an alert type

Setup alert

Exclusive Content

Privacy Preferences
